Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30123% above fair value
$273.40−16.52 (-5.70%)
Close on Nov 20, 2026Market cap $39.41BP/E –Yield –
Natera gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Natera's gross profit for the twelve months ending Jun 30, 2020 was $169.04M, up 66.0% year over year. For fiscal 2018 it was $99.57M, up 34.3% from the year before. The highest annual figure on record is $99.57M in fiscal 2018.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $99.57M | +34.3% |
| FY2017 | Dec 31, 2017 | $74.12M | -5.0% |
| FY2016 | Dec 31, 2016 | $78.02M | +0.7% |
| FY2015 | Dec 31, 2015 | $77.51M | -4.2% |
| FY2014 | Dec 31, 2014 | $80.89M | +352.0% |
| FY2013 | Dec 31, 2013 | $17.90M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $43.74M | +43.3% |
| Q1 FY2020 | Mar 31, 2020 | $52.49M | +123.2% |
| Q4 FY2019 | Dec 31, 2019 | $38.78M | +60.4% |
| Q3 FY2019 | Sep 30, 2019 | $34.03M | +44.2% |
| Q2 FY2019 | Jun 30, 2019 | $30.53M | +38.3% |
| Q1 FY2019 | Mar 31, 2019 | $23.52M | +8.2% |
| Q4 FY2018 | Dec 31, 2018 | $24.18M | +57.8% |
| Q3 FY2018 | Sep 30, 2018 | $23.60M | +10.8% |
| Q2 FY2018 | Jun 30, 2018 | $22.07M | +24.5% |
| Q1 FY2018 | Mar 31, 2018 | $21.75M | +38.7% |
| Q4 FY2017 | Dec 31, 2017 | $15.33M | +35.6% |
| Q3 FY2017 | Sep 30, 2017 | $21.30M | +8.5% |
| Q2 FY2017 | Jun 30, 2017 | $17.72M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.68M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $19.63M | – |
See a number that looks wrong?